the aid library

LIST OPTIONS

Filter

6082

Sort by:

Direction:

Download (249)

View PDF (335)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (144)

View PDF (158)

Clinical management of COVID-19: Living guideline, 18 August 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

Download (53)

View PDF (65)

Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories

Globan Burden of Disease 2020 Health Financing Collaborator Network The Lancet (2021) CC

The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was di... more

Download (149)

View PDF (228)

Recomendaciones importantes sobre el agua, el saneamiento y la higiene COVID-19 en la comunidad

World Health Organization (WHO) (2020) CC

Las mejores prácticas de agua, saneamiento e higiene, en particular el lavado de manos con jabón y agua limpia, deben aplicarse y mantenerse estrictamente, ya que constituyen una barrera adicional importante para la transmisión de COVID-19 y para la transmisión de enfermedades infecciosas en gen... more

Download (122)

View PDF (189)

Considerations and Principles for Shielding People at High Risk of Severe Outcomes from COVID-19

Social Science in Humanitarian Action (2020) CC

This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline... more

Download (126)

View PDF (181)

Policy Brief: COVID-19 and the Need for Action on Mental Health (13 May 2020)

United Nations (2020) CC

Although the COVID-19 crisis is, in the first instance, a physical health crisis, it has the seeds of a major mental health crisis as well, if action is not taken. Good mental health is critical to the functioning of society at the best of times. It must be front and centre of every country’s resp... more

Download (153)

View PDF (153)

Women and Girls Safe Spaces: Technical Guidance Note for COVID-19

Norwegian Church Aid, International Medical Corps, International Red Cross (2020) CC

This guidance note aims to provide practical support to service providers operating Women and Girls Safe Spaces (WGSS) on how to adapt programming in the context of the COVID-19 pandemic.

Download (93)

View PDF (121)

Update of the WHO recommendations for vaccination against COVID-19 - Infographic

World Health Organisation (WHO) (2023) C_WHO

The updates are based on evidence emerging from the: Ongoing monitoring of the disease. Protection that the population already developed against COVID-19 through previous infection or vaccination. Epidemiological situation, availability of diagnostic tests and access to therapeutic options.

Download (185)

View PDF (280)

Working With the Environment to Protect People: UNEP’s COVID-19 Response

UN environment programme (2020) CC

The United Nations Environment Programme (UNEP) is stepping up its work on mapping zoonotic threat and protecting the environment to reduce the risk of future pandemics, such as the COVID-19 crisis currently sweeping the globe.

Download (129)

View PDF (181)

Travailler en Symbiose Avec la Nature pour Protéger les Populations - Réponse du PNUE à la COVID-19

UN environment programme (UNEP) (2020) CC

Le Programme des Nations Unies pour l’environnement (PNUE) soutient les milliards de personnes touchées par la pandémie de COVID-19. Dans l’immédiat, la priorité est de les protéger. Toutefois, il incombe également au PNUE d’aider les pays à se reconstruire après la pandémie pour qu�... more

Download (148)

View PDF (234)

Adjusting business models to sustain agri-food enterprises during COVID-19

Food and Agriculture Organization of the United Nations (FAO) (2020) CC

Unlike foot and mouth disease, the avian flu, e-coli or listeria, the COVID-19 pandemic has not spread directly through livestock or agriculture commodities, and has therefore not directly disrupted on-farm production. However, the crisis is undermining the ability of farms and agri-enterprises to e... more

Download (148)

View PDF (193)

COVID-19 Supply Chain System:Requesting and Receiving Supplies

World Health Organisation (2020) C_WHO

The global COVID-19 outbreak is leading to an acute and drastic shortage of essential supplies, including personal protective equipment, diagnostics and clinical management. At the request of the UN Secretary-General and in support of the UN Crisis Management Team, a Supply Chain Tas... more

Download (145)

View PDF (198)

EASO Special Report: Asylum Trends and COVID-19, Issue 2 (11 June 2020)

European Asylum Support Office (2020) CC

Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February. The European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restr... more

Download (52)

View PDF (843)

COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over time

Gomes Machado, F.C. et al. (2022) CC

The Lancet Regional Health, July 19, 2022 DOI:https://doi.org/10.1016/j.lana.2022.100319

Download (80)

View PDF (1126)

Ukraine – Russia crisis and its impacts on the mental health of Ukrainian young people during the COVID-19 pandemic

Chaaya, C. et al. (2022) C1

Annals of Medicine and Surgery, 79 (2022)104033

Download (122)

View PDF (167)

Manual del Vacunador Vacuna MODERNA para uso pediátrico de 6 a 11 años Campaña Nacional de Vacunación contra la COVID-19

Feraud, H. Ministerio de Salud Argentina (2022) C2

El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.

Download (97)

View PDF (130)

Guía para madres, padres, cuidadores y educadores sobre el Coronavirus (COVID-19)

UN Children's Fund UNICEF (2020) C_UNICEF

Información sobre el nuevo Coronavirus (COVID-19) con una guía de acciones que los padres, madres, cuidadores y docentes deben saber para explicar y proteger a las niñas, niños y adolescentes.

Download (59)

View PDF (246)

COVID-19 Results Briefing Peru

Institute for Health Metrics and Evaluation (2022) CC

This document contains summary information on the latest projections from the IHME model on COVID-19 in Peru. The model was run on July 15, 2022, with data through July 10, 2022.

Download (91)

View PDF (104)

The impact of cOVID-19 on the lives of indigenous women and their strategies to deal with the pandemic

Zapeta, T.; Fenly Mejia, N. International Indigenous Women (2020) C1

The International Forum of Indigenous Women (IIWF) has prepared this report in order to have a document for analysis and systematization of the impacts of the COVID-19 pandemic on the lives of Indigenous Women, and to identify the strategies promoted by them. This document is expected to serve as... more

Download (134)

View PDF (177)

Manejo clínico de la covid-19 en Adultos

Asociación Colombiana de Infectología (2020) C2

Estas imágenes pertenecen al CONSENSO COLOMBIANO DE ATENCIÓN, DIAGNÓSTICO Y MANEJO DE LA INFECCIÓN POR SARS- CoV2/COVID- 19 EN ESTABLECIMIENTOS DE ATENCIÓN DE LA SALUD 29/08/2020